After the UK medical regulator approved the coronavirus vaccine jointly developed by Pfizer and BioNtech on Wednesday, the rest of the world is making great efforts to get inoculation tests done as early as January 2021.
The Australian pharmaceutical regulator, Therapeutic Goods Administration (TGA), said Thursday that to review Pfizer’s COVID-19 vaccine by January 2021, with the aim of starting the first vaccination in March 2021.
On Wednesday, the Prime Minister of the Canadian province of Alberta said the country expects the arrival of the vaccine from January 4, 2021, relaying information from the country’s federal government.
Market reaction
Concerns about the growth of the coronavirus have resurfaced, offsetting optimism for vaccines in Asia.
S&P 500 futures are trading modestly unchanged near the 3,670 region.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
